Daniel J. Hicklin
2021
In 2021, Daniel J. Hicklin earned a total compensation of $2.5M as President and Chief Executive Officer at Werewolf Therapeutics, a 18% decrease compared to previous year.
Compensation breakdown
| Bonus | $263,000 |
|---|---|
| Option Awards | $1,699,676 |
| Salary | $498,466 |
| Other | $1,406 |
| Total | $2,462,548 |
Hicklin received $1.7M in option awards, accounting for 69% of the total pay in 2021.
Hicklin also received $263K in bonus, $498.5K in salary and $1.4K in other compensation.
Rankings
In 2021, Daniel J. Hicklin's compensation ranked 5,211th out of 12,415 executives tracked by ExecPay. In other words, Hicklin earned more than 58.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,211 out of 12,415 | 58th |
Division Manufacturing | 2,191 out of 5,508 | 60th |
Major group Chemicals And Allied Products | 950 out of 2,378 | 60th |
Industry group Drugs | 849 out of 2,099 | 60th |
Industry Pharmaceutical Preparations | 610 out of 1,549 | 61st |
Source: SEC filing on April 22, 2022.
Hicklin's colleagues
We found four more compensation records of executives who worked with Daniel J. Hicklin at Werewolf Therapeutics in 2021.